135 related articles for article (PubMed ID: 30252977)
1. Intrapatient Comparison of the Hepatobiliary Phase of Gd-BOPTA and Gd-EOB-DTPA in the Differentiation of Hepatocellular Adenoma From Focal Nodular Hyperplasia.
Vanhooymissen IJSML; Thomeer MG; Braun LMM; Gest B; van Koeverden S; Willemssen FE; Hunink M; De Man RA; Ijzermans JN; Dwarkasing RS
J Magn Reson Imaging; 2019 Mar; 49(3):700-710. PubMed ID: 30252977
[TBL] [Abstract][Full Text] [Related]
2. HBP-enhancing hepatocellular adenomas and how to discriminate them from FNH in Gd-EOB MRI.
Auer TA; Walter-Rittel T; Geisel D; Schöning W; Schmelzle M; Müller T; Sinn B; Denecke T; Hamm B; Fehrenbach U
BMC Med Imaging; 2021 Feb; 21(1):28. PubMed ID: 33588783
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Value of Gadoxetic Acid-Enhanced MR Imaging to Distinguish HCA and Its Subtype from FNH: A Systematic Review.
Guo Y; Li W; Cai W; Zhang Y; Fang Y; Hong G
Int J Med Sci; 2017; 14(7):668-674. PubMed ID: 28824299
[No Abstract] [Full Text] [Related]
4. Comparison of the Ability of Gadobenate Dimeglumine and Gadolinium Ethoxybenzyl Dimeglumine to Display the major Features for Noninvasively Diagnosing Hepatocellular Carcinoma According to the LI-RADS 2018v.
Yao WW; Zhang HW; M YP; Lee JM; Lee RT; Wang YL; Liu XL; Shen XP; Huang B; Lin F
Technol Cancer Res Treat; 2024; 23():15330338241260331. PubMed ID: 38860337
[TBL] [Abstract][Full Text] [Related]
5. Association Between Gadoxetic Acid-Enhanced Magnetic Resonance Imaging, Organic Anion Transporters, and Farnesoid X Receptor in Benign Focal Liver Lesions.
van Rosmalen BV; Visentin M; Furumaya A; van Delden OM; Kazemier G; van Gulik TM; Verheij J; Stieger B
Drug Metab Dispos; 2024 Jan; 52(2):118-125. PubMed ID: 38050024
[TBL] [Abstract][Full Text] [Related]
6. T1 mapping of the myocardium: intra-individual assessment of post-contrast T1 time evolution and extracellular volume fraction at 3T for Gd-DTPA and Gd-BOPTA.
Kawel N; Nacif M; Zavodni A; Jones J; Liu S; Sibley CT; Bluemke DA
J Cardiovasc Magn Reson; 2012 Apr; 14(1):26. PubMed ID: 22540153
[TBL] [Abstract][Full Text] [Related]
7. Evaluation and Prognostication of Gd-EOB-DTPA MRI and CT in Patients With Macrotrabecular-Massive Hepatocellular Carcinoma.
Cheng J; Li X; Wang L; Chen F; Li Y; Zuo G; Pei M; Zhang H; Yu L; Liu C; Wang J; Han Q; Cai P; Li X
J Magn Reson Imaging; 2024 Jun; 59(6):2071-2081. PubMed ID: 37840197
[TBL] [Abstract][Full Text] [Related]
8. Partition coefficients for gadolinium chelates in the normal myocardium: comparison of gadopentetate dimeglumine and gadobenate dimeglumine.
Kawel N; Nacif M; Santini F; Liu S; Bremerich J; Arai AE; Bluemke DA
J Magn Reson Imaging; 2012 Sep; 36(3):733-7. PubMed ID: 22488770
[TBL] [Abstract][Full Text] [Related]
9. To assess the quantitative features of focal liver lesions in gadoxetic acid enhanced MRI and to determine whether these features can accurately differentiate benign form malignant lesions.
Rybczynska DN; Markiet KE; Pienkowska JM; Szurowska E; Frydrychowski A
Eur J Radiol; 2024 Feb; 171():111288. PubMed ID: 38194844
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of MRI features of hepatocyte nuclear factor 1α-inactivated hepatocellular adenoma].
Pan H; Chen XF; Han J; Ji Y; Zeng MS; Wang ML
Zhonghua Gan Zang Bing Za Zhi; 2023 Nov; 31(11):1192-1197. PubMed ID: 38238954
[No Abstract] [Full Text] [Related]
11. Differences in the Diagnosis and Treatment of Patients with Early-Stage Hepatocellular Liver Cancer by Multi-Row Spiral CTMDCT and Gd-EOB-DTPA-Enhanced MRI.
Wang K; Jin X; Zhou J; Wang Z; Zhang X
Altern Ther Health Med; 2024 Jan; 30(1):31-35. PubMed ID: 37773658
[TBL] [Abstract][Full Text] [Related]
12. Correlation of histologic, imaging, and artificial intelligence features in NAFLD patients, derived from Gd-EOB-DTPA-enhanced MRI: a proof-of-concept study.
Bastati N; Perkonigg M; Sobotka D; Poetter-Lang S; Fragner R; Beer A; Messner A; Watzenboeck M; Pochepnia S; Kittinger J; Herold A; Kristic A; Hodge JC; Traussnig S; Trauner M; Ba-Ssalamah A; Langs G
Eur Radiol; 2023 Nov; 33(11):7729-7743. PubMed ID: 37358613
[TBL] [Abstract][Full Text] [Related]
13. Gd-EOB MRI for HCC subtype differentiation in a western population according to the 5
Auer TA; Halskov S; Fehrenbach U; Nevermann NF; Pelzer U; Mohr R; Hamm B; Schöning W; Horst D; Ihlow J; Geisel D
Eur Radiol; 2023 Oct; 33(10):6902-6915. PubMed ID: 37115216
[TBL] [Abstract][Full Text] [Related]
14. Does gadoxetate disodium affect MRE measurements in the delayed hepatobiliary phase?
Plaikner M; Kremser C; Zoller H; Steurer M; Glodny B; Jaschke W; Henninger B
Eur Radiol; 2019 Feb; 29(2):829-837. PubMed ID: 30027410
[TBL] [Abstract][Full Text] [Related]
15. MRI of Focal Liver Lesions.
Albiin N
Curr Med Imaging Rev; 2012 May; 8(2):107-116. PubMed ID: 23049491
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of the performance of hepatobiliary agents in depicting MRI features of microvascular infiltration in hepatocellular carcinoma.
Yao WW; Zhang HW; Ma YP; Lee JM; Lee RT; Wang YL; Liu XL; Shen XP; Huang B; Lin F
Abdom Radiol (NY); 2024 Jun; ():. PubMed ID: 38824474
[TBL] [Abstract][Full Text] [Related]
17. Gd-EOB-DTPA-enhanced MRI for evaluation of liver function: Comparison between signal-intensity-based indices and T1 relaxometry.
Haimerl M; Verloh N; Zeman F; Fellner C; Nickel D; Lang SA; Teufel A; Stroszczynski C; Wiggermann P
Sci Rep; 2017 Mar; 7():43347. PubMed ID: 28266528
[TBL] [Abstract][Full Text] [Related]
18. Non-contrast T1ρ dispersion versus Gd-EOB-DTPA-enhanced T1mapping for the risk stratification of non-alcoholic fatty liver disease in rabbit models.
Yang R; Chen Z; Pan J; Yang S; Hu F
Magn Reson Imaging; 2024 Apr; 107():130-137. PubMed ID: 38278311
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and contrast-enhanced ultrasound in the detection of intrahepatic lesion.
Li J; Ye X; Wang J; Yuan G; He S
Medicine (Baltimore); 2022 Sep; 101(36):e30482. PubMed ID: 36086711
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
